{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:32:54Z","timestamp":1793111574031,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s11695-026-08954-1","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:25:44Z","timestamp":1790551544000},"page":"5806-5816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment With a GLP-1 Receptor Agonist Versus Reduction of the Gastrojejunal Anastomosis Diameter Using Endoscopic Argon Plasma Coagulation for Recurrent Weight Gain After Roux-en-Y Gastric Bypass"],"prefix":"10.1007","volume":"36","author":[{"given":"Sara","family":"Mera-Carreiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ramos-Lev\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mat\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Bernaldo-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rodr\u00edguez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Marcuello-Foncillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"P\u00e9rez-Ferre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Torres-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-286X","authenticated-orcid":false,"given":"Andr\u00e9s","family":"S\u00e1nchez-Pernaute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-960X","authenticated-orcid":false,"given":"Jose Miguel","family":"Esteban-L\u00f3pez-Jamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0495-6240","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Rubio-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"8954_CR1","unstructured":"World Obesity Federation. World Obesity Atlas 2023 [Internet]. London: World Obesity Federation. 2023. Available at: https:\/\/data.worldobesity.org\/publications\/ Accessed 5 Oct 2025"},{"issue":"7 Suppl","key":"8954_CR2","first-page":"s176","volume":"22","author":"CM Apovian","year":"2016","unstructured":"Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176\u201385.","journal-title":"Am J Manag Care"},{"issue":"4","key":"8954_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7861\/clinmed.2023-0144","volume":"23","author":"E Melson","year":"2023","unstructured":"Melson E, Lim VJ, Tahrani AA. Future therapies for obesity. Clin Med (Lond). 2023;23(4):337\u201346.","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"8954_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.soard.2015.04.011","volume":"12","author":"NR Obeid","year":"2016","unstructured":"Obeid NR, Malick W, Concors SJ, Fielding GA, Kurian MS, Ren-Fielding CJ. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11\u201320.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"8954_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.21037\/gs.2016.12.02","volume":"5","author":"A Maleckas","year":"2016","unstructured":"Maleckas A, Gudaityte R, Petereit R, Venclauskas L, Velickiene D. Weight regain after gastric bypass: etiology and treatment options. Gland Surg. 2016;5(6):617\u201324.","journal-title":"Gland Surg"},{"issue":"4","key":"8954_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.soard.2010.10.019","volume":"7","author":"K Higa","year":"2011","unstructured":"Higa K, Ho T, Tercero F, Yunus T, Boone KB. Laparoscopic Roux-enY gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7(4):516\u201325.","journal-title":"Surg Obes Relat Dis"},{"issue":"7","key":"8954_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.soard.2022.04.012","volume":"18","author":"SF Majid","year":"2022","unstructured":"Majid SF, Davis MJ, Ajmal S, Al-Haddad M, Al-Sabah S, Ambe P, et al. Current state of the definition and terminology related to weight recurrence after metabolic surgery: review by the POWER Task Force of the American Society for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(7):957\u201363.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"8954_CR8","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1007\/s11695-024-07489-7","volume":"34","author":"A Haddad","year":"2024","unstructured":"Haddad A, Suter M, Greve JW, Shikora S, Prager G, Abu Dayyeh B, et al. Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement. Obes Surg. 2024;34(11):3944\u201362.","journal-title":"Obes Surg"},{"issue":"15","key":"8954_CR9","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/jama.2018.14433","volume":"320","author":"WC King","year":"2018","unstructured":"King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320(15):1560.","journal-title":"JAMA"},{"issue":"9","key":"8954_CR10","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1007\/s11695-021-05497-5","volume":"31","author":"M Torrego-Ellacur\u00eda","year":"2021","unstructured":"Torrego-Ellacur\u00eda M, Barabash A, Larrad-Sainz A, Hern\u00e1ndez-Nu\u00f1ez GM, Mat\u00eda-Mart\u00edn P, P\u00e9rez-Ferre N, Marcuello C, S\u00e1nchez-Pernaute A, Torres AJ, Calle-Pascual AL, Rubio MA. Weight Regain Outcomes After Bariatric Surgery in the Long-term Follow-up: Role of Preoperative Factors. Obes Surg. 2021;31(9):3947\u201355. https:\/\/doi.org\/10.1007\/s11695-021-05497-5.","journal-title":"Obes Surg"},{"issue":"1","key":"8954_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11695-023-06913-8","volume":"34","author":"P Salminen","year":"2024","unstructured":"Salminen P, Suter M, Aras \u00d6, Cohen RV, De Luca M, Greve JW, et al. IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study. Obes Surg. 2024;34(1):30\u201342.","journal-title":"Obes Surg"},{"issue":"Suppl 1","key":"8954_CR12","doi-asserted-by":"publisher","first-page":"znaf288077","DOI":"10.1093\/bjs\/znaf288.077","volume":"113","author":"F Amorim-Cruz","year":"2026","unstructured":"Amorim-Cruz F, Magalh\u00e3es Moura AI, Coutinho C, Sousa-Pinto B, Santos-Sousa H. Definition and predictors of weight regain after metabolic bariatric surgery: a systematic review and meta-analysis [abstract]. BJS. 2026;113(Suppl 1):znaf288077. https:\/\/doi.org\/10.1093\/bjs\/znaf288.077.","journal-title":"BJS"},{"issue":"8","key":"8954_CR13","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00464-021-08329-w","volume":"35","author":"DI Athanasiadis","year":"2021","unstructured":"Athanasiadis DI, Martin A, Kapsampelis P, Monfared S, Stefanidis D. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc. 2021;35(8):4069\u201384.","journal-title":"Surg Endosc"},{"issue":"12","key":"8954_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","volume":"377","author":"TD Adams","year":"2017","unstructured":"Adams TD, Davidson LE, Litwin SE, Kim J, Wiess D, Cho Y, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143\u201355.","journal-title":"N Engl J Med"},{"issue":"3","key":"8954_CR15","doi-asserted-by":"publisher","first-page":"e046407","DOI":"10.1136\/bmjopen-2020-046407","volume":"11","author":"M Brissman","year":"2021","unstructured":"Brissman M, Beamish AJ, Olbers T, Marcus C. Prevalence of insufficient weight loss 5 years after Roux-en-Y gastric bypass: metabolic consequences and prediction estimates: a prospective registry study. BMJ Open. 2021;11(3):e046407.","journal-title":"BMJ Open"},{"issue":"11","key":"8954_CR16","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s11695-019-04109-7","volume":"29","author":"SE Hanvold","year":"2019","unstructured":"Hanvold SE, Vinknes KJ, L\u00f8ken EB, Kulseng BE, Hjelmesaeth J, Juvik J, et al. Does lifestyle intervention after gastric bypass surgery prevent weight regain? A randomized clinical trial. Obes Surg. 2019;29(11):3419\u201331.","journal-title":"Obes Surg"},{"key":"8954_CR17","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1007\/s11695-022-06191-w","volume":"32","author":"VM Dharmaratnam","year":"2022","unstructured":"Dharmaratnam VM, Lim E, Eng A, Liau S, Huang K, Lim JK, et al. Revisional surgery or pharmacotherapy for insufficient weight loss and weight regain after primary bariatric procedure: a descriptive study. Obes Surg. 2022;32:3298\u2013304.","journal-title":"Obes Surg"},{"issue":"6","key":"8954_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.gie.2020.07.013","volume":"92","author":"V Jaruvongvanich","year":"2020","unstructured":"Jaruvongvanich V, Vantanasiri K, Laoveeravat P, Vlasic G, Vilar-Gomez E, Sae-Jung S. Endoscopic full-thickness suturing plus argon plasma mucosal coagulation versus argon plasma mucosal coagulation alone for weight regain after gastric bypass: a systematic review and meta-analysis. Gastrointest Endosc. 2020;92(6):1164\u2013e756.","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"8954_CR19","doi-asserted-by":"publisher","first-page":"e13811","DOI":"10.1111\/obr.13811","volume":"25","author":"A Esparham","year":"2024","unstructured":"Esparham A, Mehri A, Dalili A, Richards J, Khorgami Z. Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis. Obes Rev. 2024;25(11):e13811. https:\/\/doi.org\/10.1111\/obr.13811.","journal-title":"Obes Rev"},{"issue":"9","key":"8954_CR20","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s11695-018-3229-5","volume":"28","author":"RC Moon","year":"2018","unstructured":"Moon RC, Teixeira AF, Galvao Neto M, Zundel N, Sander BQ, Ramos FM, et al. Efficacy of Utilizing Argon Plasma Coagulation for Weight Regain in Roux-en-Y Gastric Bypass Patients: a Multi-center Study. Obes Surg. 2018;28(9):2737\u201344. https:\/\/doi.org\/10.1007\/s11695-018-3229-5.","journal-title":"Obes Surg"},{"issue":"5","key":"8954_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.gie.2019.11.044","volume":"91","author":"P Jirapinyo","year":"2020","unstructured":"Jirapinyo P, Kumar N, AlSamman MA, Kr\u00f6ner PT, Sae-Jung S, Vlasic G, et al. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2020;91(5):1067\u201373.","journal-title":"Gastrointest Endosc"},{"key":"8954_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863. https:\/\/doi.org\/10.3389\/fpsyg.2013.00863.","journal-title":"Front Psychol"},{"issue":"11","key":"8954_CR23","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1002\/oby.21629","volume":"24","author":"K Fujioka","year":"2016","unstructured":"Fujioka K, O\u2019Neil PM, Davies M, Greenway F, Lau DCW, Claudius B, Skj\u00f8th TV, Jensen CB, Wilding JPH. Early weight loss with liraglutide 3.0\u00a0mg predicts 1-year weight loss and is associated with improvements in clinical markers. Obes (Silver Spring). 2016;24(11):2278\u201388. https:\/\/doi.org\/10.1002\/oby.21629 . PMID:27804269; PMCID:PMC5129670.","journal-title":"Obes (Silver Spring)"},{"issue":"7","key":"8954_CR24","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1210\/clinem\/dgab091","volume":"106","author":"K Kheniser","year":"2021","unstructured":"Kheniser K, Saxon DR, Kashyap SR. Long-term weight loss strategies for obesity. J Clin Endocrinol Metab. 2021;106(7):1854\u201366. https:\/\/doi.org\/10.1210\/clinem\/dgab091.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"8954_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/oby.23673","volume":"31","author":"S Wharton","year":"2023","unstructured":"Wharton S, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effect of semaglutide 2.4\u00a0mg on control of eating in adults with overweight\/obesity: STEP 5. Obes (Silver Spring). 2023;31(3):703\u201315. https:\/\/doi.org\/10.1002\/oby.23673.","journal-title":"Obes (Silver Spring)"},{"issue":"10","key":"8954_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMoa2410819","volume":"392","author":"AM Jastreboff","year":"2025","unstructured":"Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, et al. SURMOUNT-1 Investigators. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025;392(10):958\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2410819.","journal-title":"N Engl J Med"},{"issue":"8","key":"8954_CR27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","volume":"30","author":"PP Gleason","year":"2024","unstructured":"Gleason PP, Urick BY, Marshall LZ, Friedlander N, Qiu Y, Leslie RS. Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. J Manag Care Spec Pharm. 2024;30(8):860\u20137. https:\/\/doi.org\/10.18553\/jmcp.2024.23332.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"8954_CR28","doi-asserted-by":"publisher","first-page":"e002517","DOI":"10.1136\/bmjdrc-2021-002517","volume":"10","author":"T Weiss","year":"2022","unstructured":"Weiss T, Yang L, Carr RD, Pal S, Sawhney B, Boggs R, et al. Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK. BMJ Open Diabetes Res Care. 2022;10(1):e002517. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002517.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"10","key":"8954_CR29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamasurg.2023.2930","volume":"158","author":"J Mok","year":"2023","unstructured":"Mok J, Adeleke MO, Brown A, Magee CG, Firman C, Makahamadze C, Jassil FC, Marvasti P, Carnemolla A, Devalia K, Fakih N, Elkalaawy M, Pucci A, Jenkinson A, Adamo M, Omar RZ, Batterham RL, Makaronidis J. Safety and Efficacy of Liraglutide, 3.0\u00a0mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial. JAMA Surg. 2023;158(10):1003\u201311. https:\/\/doi.org\/10.1001\/jamasurg.2023.2930.","journal-title":"JAMA Surg"},{"issue":"2","key":"8954_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11695-023-07053-9","volume":"34","author":"F Vinciguerra","year":"2024","unstructured":"Vinciguerra F, Di Stefano C, Baratta R, Pulvirenti A, Mastrandrea G, Piazza L, Guccione F, Navarra G, Frittitta L. Efficacy of High-dose Liraglutide 3.0\u00a0mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis. Obes Surg. 2024;34(2):303\u20139. https:\/\/doi.org\/10.1007\/s11695-023-07053-9.","journal-title":"Obes Surg"},{"issue":"2","key":"8954_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11695-025-07723-w","volume":"35","author":"J Kellett","year":"2025","unstructured":"Kellett J, Soliman SS, Podwojniak A, Minkanic M, Kumar G, Goodwin B, Yang HJ, Elsawwah JK, Nemeth ZH. The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic\/Bariatric Surgery: A Systematic Review and Meta-analysis. Obes Surg. 2025;35(2):630\u201341.","journal-title":"Obes Surg"},{"issue":"3","key":"8954_CR32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11695-025-07733-8","volume":"35","author":"Y Nie","year":"2025","unstructured":"Nie Y, Zhang Y, Liu B, Meng H. Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg. 2025;35(3):808\u201322.","journal-title":"Obes Surg"},{"issue":"2","key":"8954_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/jama.2021.23619","volume":"327","author":"DM Rubino","year":"2022","unstructured":"Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138\u201350. https:\/\/doi.org\/10.1001\/jama.2021.23619.","journal-title":"JAMA"},{"issue":"1","key":"8954_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","volume":"393","author":"LJ Aronne","year":"2025","unstructured":"Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C. Dunn JP, for the SURMOUNT-5 Trial Investigators. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025;393(1):26\u201336. https:\/\/doi.org\/10.1056\/NEJMoa2416394.","journal-title":"N Engl J Med"},{"key":"8954_CR35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s11695-024-07137-0","volume":"34","author":"M Jamal","year":"2024","unstructured":"Jamal M, Alhashemi M, Dsouza C, Al-hassani S, Qasem W, Almazeedi S, et al. Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study. Obes Surg. 2024;34:1324\u201332. https:\/\/doi.org\/10.1007\/s11695-024-07137-0.","journal-title":"Obes Surg"},{"issue":"3","key":"8954_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.gie.2020.07.013","volume":"97","author":"V Jaruvongvanich","year":"2023","unstructured":"Jaruvongvanich V, Vantanasiri K, Laoveeravat P, Matar RH, Vargas EJ, Maselli DB, Alkhatry M, Fayad L, Kumbhari V, Fittipaldi-Fernandez RJ, Hollenbach M, Watson RR, de Quadros LG, Galvao Neto M, Aepli P, Staudenmann D, Brunaldi VO, Storm AC, Martin JA, Gomez V, Abu Dayyeh BK. Endoscopic full-thickness suturing plus argon plasma mucosal coagulation versus argon plasma mucosal coagulation alone for weight regain after gastric bypass: a systematic review and meta-analysis. Gastrointest Endosc. 2023;97(3):477\u2013e4884. https:\/\/doi.org\/10.1016\/j.gie.2020.07.013.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"8954_CR37","first-page":"e12487","volume":"12","author":"RJ Franken","year":"2022","unstructured":"Franken RJ, Franken J, Sluiter NR, de Vries R, Euser S, Gerdes VEA, de Brauw M. Efficacy and safety of revisional treatments for weight regain or insufficient weight loss after Roux-en-Y gastric bypass: A systematic review and meta-analysis. Clin Obes. 2022;12(1):e12487.","journal-title":"Clin Obes"},{"issue":"3","key":"8954_CR38","first-page":"e1530","volume":"33","author":"GC Gurian","year":"2020","unstructured":"Gurian GC, Watanabe LM, Nonino CB, Barato M, Ferreira-Julio MA, Arantes FA, Sivieri T, Noronha NY, Souza DSR, Fernandes-Ferreira R, de Souza Pinhel MA. Efficacy of the argon plasma coagulation in patients with weight regain after gastric bypass: a randomized control trial. Arq Bras Cir Dig. 2020;33(3):e1530.","journal-title":"Arq Bras Cir Dig"},{"issue":"4","key":"8954_CR39","first-page":"612","volume":"90","author":"P Jirapinyo","year":"2019","unstructured":"Jirapinyo P, de Moura DTH, Dong WY, Farias G, Thompson CC. Dose response for argon plasma coagulation in the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2019;90(4):612\u2013e6181.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"8954_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.gie.2025.05.020","volume":"102","author":"P Jirapinyo","year":"2025","unstructured":"Jirapinyo P, Kumar N, Thompson CC, Law RJ, Muthusamy VR, Schulman AR, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy preservation and incorporation of valuable endoscopic innovations thresholds for transoral outlet reduction. Gastrointest Endosc. 2025;102(4):440\u2013e4536. https:\/\/doi.org\/10.1016\/j.gie.2025.05.020.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"8954_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s11695-025-07671-5","volume":"35","author":"A Lahooti","year":"2025","unstructured":"Lahooti A, Hoff AC, Critelli B, Hassan A, Westerveld D, Hajifathalian K, Dawod E, Akagbosu CO, Aljohani W, Hassan K, Nunes GC, Barrichello S, Neto MG, Scarparo J, Newberry C, Kumar S, Sharaiha RZ. A Randomized, Double-Blind, Two-Way Cross-over Study to Evaluate the Efficacy of Liraglutide Treatment in Patients Undergoing Transoral Outlet Reduction Endoscopy for Weight Regain Post Roux-en-Y Gastric Bypass. Obes Surg. 2025;35(3):775\u201383. https:\/\/doi.org\/10.1007\/s11695-025-07671-5.","journal-title":"Obes Surg"},{"issue":"3","key":"8954_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cgh.2010.11.004","volume":"9","author":"BK Abu Dayyeh","year":"2011","unstructured":"Abu Dayyeh BK, Lautz DB, Thompson CC. Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol. 2011;9(3):228\u201333. https:\/\/doi.org\/10.1016\/j.cgh.2010.11.004. Epub 2010 Nov 17. PMID: 21092760; PMCID: PMC3043151.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"8954_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11695-021-05795-y","volume":"32","author":"M Galvao Neto","year":"2022","unstructured":"Galvao Neto M, Brunaldi VO, Grecco E, Silva LB, de Quadros LG, de Souza TF, Teixeira A, de Morais HWP, de Lima JHF, Concon Filho A, Amorim A, de Santana MF, Teixeira N, Marchesini JC. Brazilian Bariatric Endoscopy Collaborative working group. Good Clinical Practices on Argon Plasma Coagulation Treatment for Weight Regain Associated with Dilated Gastrojejunostomy Following Roux-en-Y Gastric Bypass: a Brazilian-Modified Delphi Consensus. Obes Surg. 2022;32(2):273\u201383. https:\/\/doi.org\/10.1007\/s11695-021-05795-y.","journal-title":"Obes Surg"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08954-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08954-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08954-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:36:16Z","timestamp":1793108176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08954-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8954"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08954-1","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Hospital Cl\u00ednico San Carlos (C.I. 24\/011-E). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Preliminary results from this study were previously presented as a poster and published in abstract form: Carreiro SM, Madrid BB, Carrillo CR, et al. Endoscopic argon plasma coagulation (APC) vs. glucagon-like peptide-1 receptor agonists (ARGLP1) liraglutide and semaglutide for the treatment of weight regain (WR) after bariatric surgery (BS) [abstract].\n                      Clin Nutr ESPEN\n                      . 2024;63:1296.","order":2,"name":"Ethics","label":"Previous presentation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}